LVMH Moët Hennessy - Louis Vuitton, Société Européenne vs AstraZeneca PLC
Confronto della capitalizzazione di mercato nel tempo
LVMH Moët Hennessy - Louis Vuitton, Société Européenne
$237.5B
Posizione #62
AstraZeneca PLC
$243.3B
Posizione #59
Capitalizzazione di mercato nel tempo
Momenti chiave
- LVMH Moët Hennessy - Louis Vuitton, Société Européenne ha superato AstraZeneca PLC entro il 2010
- AstraZeneca PLC ha superato LVMH Moët Hennessy - Louis Vuitton, Société Européenne entro il 2013
- LVMH Moët Hennessy - Louis Vuitton, Société Européenne ha superato AstraZeneca PLC entro il 2016
- AstraZeneca PLC ha superato LVMH Moët Hennessy - Louis Vuitton, Société Européenne entro il 2026
Confronto anno per anno
| Anno | LVMH Moët Hennessy - Louis Vuitton, Société Européenne | AstraZeneca PLC | Leader |
|---|---|---|---|
| 2026 | $237.5B | $243.3B | AstraZeneca PLC |
| 2025 | $335.8B | $282.2B | LVMH Moët Hennessy - Louis Vuitton, Société Européenne |
| 2024 | $322.8B | $196.9B | LVMH Moët Hennessy - Louis Vuitton, Société Européenne |
| 2023 | $366.2B | $198.1B | LVMH Moët Hennessy - Louis Vuitton, Société Européenne |
| 2022 | $334.5B | $195.3B | LVMH Moët Hennessy - Louis Vuitton, Société Européenne |
| 2021 | $353.6B | $163.9B | LVMH Moët Hennessy - Louis Vuitton, Société Européenne |
| 2020 | $244.8B | $136.9B | LVMH Moët Hennessy - Louis Vuitton, Société Européenne |
| 2019 | $196.1B | $132.8B | LVMH Moët Hennessy - Louis Vuitton, Société Européenne |
| 2018 | $120.0B | $97.9B | LVMH Moët Hennessy - Louis Vuitton, Société Européenne |
| 2017 | $111.9B | $85.9B | LVMH Moët Hennessy - Louis Vuitton, Société Européenne |
| 2016 | $81.7B | $64.5B | LVMH Moët Hennessy - Louis Vuitton, Société Européenne |
| 2015 | $63.2B | $76.6B | AstraZeneca PLC |
| 2014 | $56.5B | $76.2B | AstraZeneca PLC |
| 2013 | $55.9B | $61.7B | AstraZeneca PLC |
| 2012 | $57.2B | $46.3B | LVMH Moët Hennessy - Louis Vuitton, Société Européenne |
| 2011 | $44.0B | $42.7B | LVMH Moët Hennessy - Louis Vuitton, Société Européenne |
| 2010 | $48.6B | $40.3B | LVMH Moët Hennessy - Louis Vuitton, Société Européenne |
| 2009 | $30.3B | $38.9B | AstraZeneca PLC |
| 2008 | $18.0B | $32.3B | AstraZeneca PLC |
| 2007 | $30.3B | $32.3B | AstraZeneca PLC |
| 2006 | $28.6B | $39.1B | AstraZeneca PLC |
| 2005 | $26.5B | $34.5B | AstraZeneca PLC |
| 2004 | $19.5B | $25.2B | AstraZeneca PLC |
| 2003 | $19.7B | $32.9B | AstraZeneca PLC |
| 2002 | $13.1B | $23.4B | AstraZeneca PLC |
| 2001 | $15.1B | $30.5B | AstraZeneca PLC |
| 2000 | $23.0B | $33.1B | AstraZeneca PLC |